WO2004084833A3 - Jucara and açai fruit-based dietary supplements - Google Patents

Jucara and açai fruit-based dietary supplements Download PDF

Info

Publication number
WO2004084833A3
WO2004084833A3 PCT/US2004/008739 US2004008739W WO2004084833A3 WO 2004084833 A3 WO2004084833 A3 WO 2004084833A3 US 2004008739 W US2004008739 W US 2004008739W WO 2004084833 A3 WO2004084833 A3 WO 2004084833A3
Authority
WO
WIPO (PCT)
Prior art keywords
fruit
jucara
dietary supplements
based dietary
açai
Prior art date
Application number
PCT/US2004/008739
Other languages
French (fr)
Other versions
WO2004084833A2 (en
WO2004084833A8 (en
Inventor
Kenneth A Murdock
Alexander G Schauss
Original Assignee
K2A Inc
Kenneth A Murdock
Alexander G Schauss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33510429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2004084833(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AT04758022T priority Critical patent/ATE549027T1/en
Priority to CA2529584A priority patent/CA2529584C/en
Priority to ES04758022T priority patent/ES2387121T3/en
Priority to EP04758022A priority patent/EP1622632B1/en
Priority to AU2004224346A priority patent/AU2004224346B2/en
Priority to PL04758022T priority patent/PL1622632T3/en
Priority to BRPI0408589-2A priority patent/BRPI0408589A/en
Priority to US10/550,502 priority patent/US7563465B2/en
Priority to CN2004800138552A priority patent/CN1791418B/en
Priority to JP2006507456A priority patent/JP2006520804A/en
Application filed by K2A Inc, Kenneth A Murdock, Alexander G Schauss filed Critical K2A Inc
Publication of WO2004084833A2 publication Critical patent/WO2004084833A2/en
Publication of WO2004084833A3 publication Critical patent/WO2004084833A3/en
Priority to KR1020057017709A priority patent/KR101166928B1/en
Publication of WO2004084833A8 publication Critical patent/WO2004084833A8/en
Priority to US12/259,977 priority patent/US20090155398A1/en
Priority to US12/259,993 priority patent/US7727564B2/en
Priority to US12/259,988 priority patent/US7700138B2/en
Priority to US12/498,269 priority patent/US7799354B2/en
Priority to US12/760,395 priority patent/US8153170B2/en
Priority to US13/442,858 priority patent/US9066975B2/en
Priority to US14/726,221 priority patent/US9526755B2/en
Priority to US14/726,266 priority patent/US9352009B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01—Instant products; Powders; Flakes; Granules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Abstract

The present invention relates to stable, palatable, freeze-dried, fruit-based dietary supplements. Specifically, the inventions relates to compositions of Açai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses. The invention further provides for methods of making stable, palatable, freeze-dried, fruit-based dietary supplements from Açai fruit and Jucara fruit.
PCT/US2004/008739 2003-03-21 2004-03-22 Jucara and açai fruit-based dietary supplements WO2004084833A2 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
US10/550,502 US7563465B2 (en) 2003-03-21 2004-03-22 Jucara and Açai fruit-based dietary supplements
BRPI0408589-2A BRPI0408589A (en) 2003-03-21 2004-03-22 acai and juçara fruit dietary supplements
ES04758022T ES2387121T3 (en) 2003-03-21 2004-03-22 Dietary supplements based on fruits of jusara and asai
EP04758022A EP1622632B1 (en) 2003-03-21 2004-03-22 Jucara and acai fruit-based dietary supplements
AU2004224346A AU2004224346B2 (en) 2003-03-21 2004-03-22 Jucara and Acai fruit-based dietary supplements
PL04758022T PL1622632T3 (en) 2003-03-21 2004-03-22 Jucara and acai fruit-based dietary supplements
CN2004800138552A CN1791418B (en) 2003-03-21 2004-03-22 Nutrition replenisher for jucara and acai fruit group
AT04758022T ATE549027T1 (en) 2003-03-21 2004-03-22 FOOD SUPPLEMENT BASED ON JUCARA AND ACAI FRUITS
CA2529584A CA2529584C (en) 2003-03-21 2004-03-22 Jucara and acai fruit-based dietary supplements
JP2006507456A JP2006520804A (en) 2003-03-21 2004-03-22 Health supplement based on Jucara and Acai fruit
KR1020057017709A KR101166928B1 (en) 2003-03-21 2005-09-21 - jucara and acai fruit-based dietary supplements
US12/259,977 US20090155398A1 (en) 2003-03-21 2008-10-28 Jucara and acai fruit-based dietary supplements
US12/259,988 US7700138B2 (en) 2003-03-21 2008-10-28 Jucara and Açai fruit-based dietary supplements
US12/259,993 US7727564B2 (en) 2003-03-21 2008-10-28 Jucara and açai fruit-based dietary supplements
US12/498,269 US7799354B2 (en) 2003-03-21 2009-07-06 Jucara and Açai fruit-based compositions
US12/760,395 US8153170B2 (en) 2003-03-21 2010-04-14 Jucara and acai fruit-based dietary supplements
US13/442,858 US9066975B2 (en) 2003-03-21 2012-04-10 Jucara and acai fruit based dietary supplements
US14/726,221 US9526755B2 (en) 2003-03-21 2015-05-29 Jucara and Açai fruit-based compositions
US14/726,266 US9352009B2 (en) 2003-03-21 2015-05-29 Jucara and Acai fruit-based compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45688203P 2003-03-21 2003-03-21
US60/456,882 2003-03-21

Related Child Applications (5)

Application Number Title Priority Date Filing Date
US10/550,502 A-371-Of-International US7563465B2 (en) 2003-03-21 2004-03-22 Jucara and Açai fruit-based dietary supplements
US12/259,977 Division US20090155398A1 (en) 2003-03-21 2008-10-28 Jucara and acai fruit-based dietary supplements
US12/259,993 Division US7727564B2 (en) 2003-03-21 2008-10-28 Jucara and açai fruit-based dietary supplements
US12/259,988 Division US7700138B2 (en) 2003-03-21 2008-10-28 Jucara and Açai fruit-based dietary supplements
US12/498,269 Continuation US7799354B2 (en) 2003-03-21 2009-07-06 Jucara and Açai fruit-based compositions

Publications (3)

Publication Number Publication Date
WO2004084833A2 WO2004084833A2 (en) 2004-10-07
WO2004084833A3 true WO2004084833A3 (en) 2005-01-20
WO2004084833A8 WO2004084833A8 (en) 2007-06-21

Family

ID=33510429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/008739 WO2004084833A2 (en) 2003-03-21 2004-03-22 Jucara and açai fruit-based dietary supplements

Country Status (12)

Country Link
US (9) US7563465B2 (en)
EP (1) EP1622632B1 (en)
JP (1) JP2006520804A (en)
KR (1) KR101166928B1 (en)
CN (2) CN101238895B (en)
AT (1) ATE549027T1 (en)
AU (1) AU2004224346B2 (en)
BR (1) BRPI0408589A (en)
CA (1) CA2529584C (en)
ES (1) ES2387121T3 (en)
PL (1) PL1622632T3 (en)
WO (1) WO2004084833A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006520804A (en) * 2003-03-21 2006-09-14 ケー２エイ インコーポレイテッド Health supplement based on Jucara and Acai fruit
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
MX2007013850A (en) 2005-05-02 2008-04-09 4Life Patents Llc Transfer factor preparations and associated methods.
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
RU2008110039A (en) * 2005-08-15 2009-09-27 Юнилевер Н.В. (Nl) STRAWING DRINK
KR101773474B1 (en) 2006-01-19 2017-09-12 마리 케이 인코포레이티드 Cosmetic composition comprising kakadu plum extract and acai berry extract
UA92784C2 (en) * 2006-01-19 2010-12-10 Мэри Кей, Инк. Compositions comprising kakadu plum extract or acai berry extract
BRPI0604281A (en) 2006-07-18 2008-03-04 Roberto Soares De Moura process for obtaining euterpe oleracea (açaì) fruit and stone clusters process for obtaining hydroalcoholic extracts from the cleavages; process of obtaining lyophilisate and / or spray dryer of the hydroalcoholic extract; pharmaceutical compositions containing the lyophilisates and / or spray dryers of said extracts and therapeutic use of the compositions as a vasodilator in the treatment of ischemic, vaso-spastic and arterial hypertension syndromes
FR2910815B1 (en) * 2006-12-28 2010-10-29 Expanscience Lab COMPOSITION COMPRISING AN EXTRACT OF QUINOA SEEDS
US20100197643A1 (en) * 2007-06-15 2010-08-05 Talcott Stephen T Phytochemical-rich oils and methods related thereto
TWI519307B (en) * 2007-10-24 2016-02-01 Suntory Holdings Ltd The ligand of peroxisome proliferator activated receptor (PPAR)
JP2009256326A (en) * 2008-03-21 2009-11-05 Kose Corp Skin whitening preparation, and skincare preparation
US20090246344A1 (en) * 2008-03-31 2009-10-01 Sasaki Tea Manufacturing Co., Ltd. Antioxidant Agent and Beverage Using Same
WO2010029578A2 (en) * 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
US9050275B2 (en) * 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
US9176146B2 (en) * 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
WO2011026202A1 (en) * 2009-09-03 2011-03-10 Universidade Do Estado Do Rio De Janeiro - Uerj Method for manufacturing smoking products containing anti-oxidant substances and thus manufactured product
US8932468B2 (en) * 2010-01-12 2015-01-13 The United States Of America As Represented By The Secretary Of The Army Separation of enzymatically synthesized polyepicatechin via high performance liquid chromatography
BRPI1003215A2 (en) * 2010-02-23 2012-03-20 Universidade Do Estado Do Rio De Janeiro - Uerj PROCESS FOR THE PREPARATION OF OINTMENTS, CONTAINING ANTIOXIDANTS OBITTED FROM PLANTS RICH IN POLYPHENOLS, FOR USE IN THE TREATMENT OF WOUNDS OF DIFFERENT ETIOLOGIES IN WHICH THERE IS AN INCREASE OF PROOXOXATING FACTORS AND / OR GREAT FORMATION OF OXYGENIC ORIENTED OXIDARY SPECIES. NITRIC OXIDE
US8828377B2 (en) 2010-03-15 2014-09-09 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
JP5818410B2 (en) * 2010-08-03 2015-11-18 長谷川香料株式会社 Fragrance composition for imparting orac value to food
BRPI1003060B1 (en) 2010-08-04 2017-03-07 Amazon Dreams Indústria E Comércio S A process of obtaining partially purified extracts of antioxidant compounds from euterpe palm fruits
US20120121763A1 (en) * 2010-11-12 2012-05-17 Marni Markell Hurwitz Pulp food product, process and method of manufacturing same
JP5821259B2 (en) 2011-04-22 2015-11-24 セイコーエプソン株式会社 Image display system, image display device, 3D glasses, and image display method
CN103648301A (en) * 2011-07-22 2014-03-19 雀巢产品技术援助有限公司 Dried pulp preparation from unprocessed raw materials
KR101317738B1 (en) * 2012-03-30 2013-10-15 이상호 an animal feed form with poultry productivity improvement and that method
JP6072545B2 (en) * 2013-01-18 2017-02-01 株式会社ミルボン Non-aqueous hair cosmetic
CN103736085B (en) * 2013-12-27 2015-07-29 南宁市品迪生物工程有限公司 A kind of medicine of prevention and therapy alzheimer disease
WO2019046444A2 (en) * 2017-08-29 2019-03-07 Flaask, Llc Compositions and methods for diagnosing susceptibility to autism spectrum disorder (asd), reducing the likelihood of developing asd, and/or treating asd
US11478494B2 (en) 2017-10-13 2022-10-25 Locus Ip Company, Llc Methods and substances for prevention and treatment of neurodegenerative diseases
MY194335A (en) * 2018-03-08 2022-11-29 Malaysian Palm Oil Board Composition for delaying ageing process and increasing longevity in a subject and methods thereof
CN114009755A (en) * 2021-09-29 2022-02-08 黑龙江飞鹤乳业有限公司 Fermentation method of assai and fermentation product
US20230155505A1 (en) * 2021-11-12 2023-05-18 Diodes Incorporated Adaptive minimum duty cycle design to extend operational voltage range for dcdc converters

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920815A (en) * 1970-04-15 1975-11-18 Mirlin Corp Taste-modifying composition
JPH06271850A (en) * 1993-03-23 1994-09-27 Nikken Food Kk Antioxidant obtained from natural product as raw material and its production
US6231866B1 (en) * 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
WO2000033670A1 (en) * 1998-12-11 2000-06-15 Michigan State University Method and compositions for producing berry derived products
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP2001046030A (en) * 1999-08-02 2001-02-20 Tama Seikagaku Kk Production of blueberry-extracted essence
CN1384713A (en) * 1999-08-27 2002-12-11 密执安州大学 Dietary food supplement containing natural cyclooxygenase inhibitors
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US7014873B2 (en) * 2001-11-14 2006-03-21 Morinda, Inc. Method and formulation for treating candidiasis using morinda citrifolia
US7182935B2 (en) * 2002-06-19 2007-02-27 Empresa Brasileira De Pesquisa Agropecuaria Embrapa Bacterial plaque evidencing composition based on natural colorants
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
JP2006520804A (en) * 2003-03-21 2006-09-14 ケー２エイ インコーポレイテッド Health supplement based on Jucara and Acai fruit
US7232585B2 (en) * 2004-06-24 2007-06-19 Xel Herbaceuticals, Inc. Green tea formulations and methods of preparation
US20080050498A1 (en) * 2004-10-07 2008-02-28 Next Proteins, Inc. Powdered protein beverage mix and methods of making the same
WO2006055550A2 (en) * 2004-11-15 2006-05-26 Borba, Llc Nutritional beverage with skin improvement aids
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
MX2007013850A (en) * 2005-05-02 2008-04-09 4Life Patents Llc Transfer factor preparations and associated methods.
US20070166253A1 (en) * 2005-05-31 2007-07-19 Velveteen Bunni Llc Cosmetic and dermatological formulations with natural pigments
US20070196298A1 (en) * 2005-05-31 2007-08-23 Kostick Richard H Cosmetic and dermatological formulations with natural pigments and methods of use
US20070065396A1 (en) * 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
US8962058B2 (en) * 2005-11-23 2015-02-24 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
KR101773474B1 (en) * 2006-01-19 2017-09-12 마리 케이 인코포레이티드 Cosmetic composition comprising kakadu plum extract and acai berry extract
CA2713525A1 (en) * 2008-02-06 2009-08-13 The Procter & Gamble Company Compositions methods and kits for enhancing immune response to a respiratory condition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOBBIO ET AL.: "Stability and stabilization of the anthocyanins fron Euterpe oleracea Mart.", ACTA ALIMETARIA, vol. 31, no. 4, 2002, pages 371 - 377, XP002995426 *
KITAGAWA ET AL.: "Optimizing the enzymatic maceration of foliole puree form hard pieces of hearts of palm (Euterpe edulis Mart.) using response surface analysis", JOURNAL OF FOOD SCIENCE, vol. 59, no. 4, 1994, pages 844 - 848, XP002995422 *

Also Published As

Publication number Publication date
JP2006520804A (en) 2006-09-14
PL1622632T3 (en) 2012-10-31
AU2004224346A1 (en) 2004-10-07
CA2529584A1 (en) 2004-10-07
US7799354B2 (en) 2010-09-21
CN1791418B (en) 2012-03-07
EP1622632A2 (en) 2006-02-08
US20150258164A1 (en) 2015-09-17
CN101238895B (en) 2011-04-13
US7727564B2 (en) 2010-06-01
WO2004084833A2 (en) 2004-10-07
CA2529584C (en) 2014-05-27
AU2004224346B2 (en) 2009-11-12
WO2004084833A8 (en) 2007-06-21
US20100239694A1 (en) 2010-09-23
CN101238895A (en) 2008-08-13
US7563465B2 (en) 2009-07-21
KR20060002838A (en) 2006-01-09
CN1791418A (en) 2006-06-21
US9352009B2 (en) 2016-05-31
US20090155398A1 (en) 2009-06-18
US7700138B2 (en) 2010-04-20
KR101166928B1 (en) 2012-08-16
US20090148390A1 (en) 2009-06-11
ATE549027T1 (en) 2012-03-15
EP1622632A4 (en) 2009-09-02
US9526755B2 (en) 2016-12-27
BRPI0408589A (en) 2006-03-21
US8153170B2 (en) 2012-04-10
US20100003355A1 (en) 2010-01-07
US20150258163A1 (en) 2015-09-17
US20060275511A1 (en) 2006-12-07
US20130095195A1 (en) 2013-04-18
US20090156513A1 (en) 2009-06-18
US9066975B2 (en) 2015-06-30
ES2387121T3 (en) 2012-09-14
EP1622632B1 (en) 2012-03-14

Similar Documents

Publication Publication Date Title
WO2004084833A3 (en) Jucara and açai fruit-based dietary supplements
WO2005120524A3 (en) Nutritional formulations
WO2006069668A8 (en) Method for producing a raw oil from mixtures of micro-organisms and plants, oil produced according to said method and specific uses of the thus produced oil and, optionally, additional refined oil
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
WO2011100763A3 (en) Ruminant dietary supplement compositions and methods of manufacturing and using the same
WO2007079139A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2006107820A3 (en) Lignan-containing compositions
WO2008031798A3 (en) Edible wafer products produced by extrusion
WO2007022312A3 (en) High protein food bars comprising sugar alcohols and having improved texture and shelf-life
WO2009085386A3 (en) Stable nutritional powder
WO2005065669A8 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
MY157678A (en) Freeze-dried,aerated fruit or vegetables compositions and methods of making thereof
WO2005082927A3 (en) Antihypertensive peptides
WO2008066380A3 (en) Process for the preparation of powdered oils
WO2005070183A3 (en) Ice cream and ice cream formulations containing maltitol
WO2009126389A3 (en) Fruit or vegetable and grain snack mixture
WO2007022313A3 (en) High protein food bars comprising sugar syrups and having improved texture and shelf-life
WO2005112965A3 (en) Botanical anti-inflammatory compositions and methods
WO2005037470A3 (en) Encapsulated nanoparticles, products containing the same, and methods for using the same
IL164089A0 (en) Astaxanthin medium-chain fatty acidester, production method of the same, and composition comprising the same
WO2003101923A3 (en) Policosanol compositions, extraction from novel sources, and uses thereof
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2007109071A3 (en) Hydroxylated polymethoxyflavone compositions
WO2006117602A3 (en) Use of amide derivatives as taste-modifying agents, flavouring compositions and products containing them
WO2004031202A3 (en) Condensed palatinose in hydrogenated form

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2529584

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020057017709

Country of ref document: KR

Ref document number: 2006507456

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004224346

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004758022

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004224346

Country of ref document: AU

Date of ref document: 20040322

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004224346

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 20048138552

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020057017709

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2004758022

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0408589

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 2006275511

Country of ref document: US

Ref document number: 10550502

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10550502

Country of ref document: US